Related Experiment Video
Updated: Sep 13, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Federated Analysis With Differential Privacy in Oncology Research: Longitudinal Observational Study Across Hospital
Théo Ryffel1, Perrine Créquit2, Maëlle Baillet1
1Arkhn, 9, rue d'Alexandrie, Paris, 75002, France.
Background:
Federated analytics in health care allows researchers to perform statistical queries on remote datasets without access to the raw data. This method arose from the need to perform statistical analysis on larger datasets collected at multiple health care centers while avoiding regulatory, governance, and privacy issues that might arise if raw data were collected at a central location outside the health care centers. Despite some pioneering work, federated analytics is still not widely used on real-world data, and to our knowledge, no real-world study has yet combined it with other privacy-enhancing techniques such as differential privacy (DP).
Objective:
The first objective of this study was to deploy a federated architecture in a real-world setting. The oncology study used for this deployment compared the medical health care management of patients with metastatic non-small cell lung cancer before and after the first wave of COVID-19 pandemic. The second goal was to test DP in this real-world scenario to assess its practicality and use as a privacy-enhancing technology.
Methods:
A federated architecture platform was set up in the Toulouse, Reims, and Foch centers. After harmonization of the data in each center, statistical analyses were performed using DataSHIELD (Data aggregation through anonymous summary-statistics from harmonized individual-level databases), a federated analysis R library, and a new open-source DP DataSHIELD package was implemented (dsPrivacy).
Results:
A total of 50 patients were enrolled in the Toulouse and Reims centers and 49 in the Foch center. We have shown that DataSHIELD is a practical tool to efficiently conduct our study across all 3 centers without exposing data on a central node, once a sufficient setup has been established to configure a secure network between hospitals. All planned aggregated results were successfully generated. We also observed that DP can be implemented in practice with promising trade-offs between privacy and accuracy, and we built a library that will prove useful for future work.
Conclusions:
The federated architecture platform made it possible to run a multicenter study on real-world oncology data while ensuring strong privacy guarantees using differential privacy.
More Related Videos
04:58Author Spotlight: Investigating the Role of Repetitive DNA Misregulation in Cancer Initiation and Immunotherapy Resistance
Published on: December 13, 2024
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Cancer Survival Analysis
Statistical Methods for Analyzing Epidemiological Data
Comparing the Survival Analysis of Two or More Groups
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Analysis of Population Pharmacokinetic Data
Longitudinal Research